Developing medical countermeasures against emerging pathogens like COVID-19
Official title: Biocontainment Research Support Service(s) Core
Funded at University of Missouri-Columbia · NIH-10910193 · Data updated 2026-11-12
This study is working on developing new vaccines and treatments for diseases like COVID-19 to help keep everyone safe, using advanced science techniques to test these solutions in a secure environment.
Quick facts
| Grant type | NIH-funded research |
|---|---|
| Study type | NIH-funded research |
| Funding institution | University of Missouri-Columbia NIH-funded |
| Lab location | 1 site (Columbia, United States) |
| Project start | August 18, 2023 |
| Project end | July 31, 2028 |
| Funding year | 2024 |
| Award (this year) | $921,558 |
| NIH project number | 5UC7AI180306-02 |
| Project ID | NIH-10910193 on NIH RePORTER |
Who could benefit from this research
✓Could help
Ideal candidates for participation or benefit from this research include individuals at risk of exposure to emerging pathogens or those affected by COVID-19.
✕Less likely to help
Patients with established immunity to COVID-19 or those not at risk of exposure to infectious diseases may not receive direct benefits from this research.
What this research studies
This research focuses on providing essential resources for the pre-clinical development of medical countermeasures targeting emerging and re-emerging pathogens, particularly those that pose a threat to public health, such as COVID-19. The Biocontainment Research Support Services Core (BRSSC) utilizes advanced techniques in aerobiology, animal modeling, immunology, imaging, and microbiology to evaluate novel vaccines, treatments, and diagnostics. Patients may benefit indirectly as the research aims to enhance the safety and efficacy of medical interventions against infectious diseases. The BRSSC operates under strict biocontainment conditions to ensure the safe handling of pathogens during experimentation.
Why it matters
Potential benefit: If successful, this research could lead to the development of effective vaccines and treatments for COVID-19 and other emerging infectious diseases.
How similar studies have gone: Other research initiatives focusing on similar biocontainment strategies have shown promise in developing effective medical countermeasures against infectious diseases.
Where this research is happening
-
University of Missouri-Columbia
Columbia, United States Active
Researchers
- Principal investigator: Olson, Rachel M — University of Missouri-Columbia
- Study coordinator: Olson, Rachel M
Related research
Other NIH-funded projects on the same topics.
-
Boosting immune response to fight cancer
This study is exploring a new way to help your immune system better fight cancer by tweaking certain cells in your body, and it aims to improve treatment for people with advanced cancer.
-
Interface between immune cells and scarring in the eye
This grant looks at how immune cells influence scar formation in the cornea after injury and how this affects vision.
-
Understanding cell-cleanup problems in C9ORF72-related ALS/FTD
Researchers are studying why the body's cell-cleanup systems fail in a genetic form of ALS/FTD to pave the way for better treatments.
-
Molecular clues to endometriosis-related infertility
This grant explores how molecular changes in endometriosis contribute to infertility, with the aim of finding better ways to diagnose and treat the condition.
-
A universal Shigella vaccine using SAVE to protect people of all ages
A new vaccine approach called SAVE aims to prevent Shigella-related dysentery across all ages, including children and adults, by targeting conserved bacterial components.
-
Biomarkers that predict osteoarthritis risk in people at higher risk
A long-term study will look for protein markers in body fluids that could predict who will develop knee osteoarthritis before symptoms appear.
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page.